Ideaya Biosciences Has Entered Into A Clinical Trial Collaboration And Supply Agreement With Merck To Evaluate Its IDEE161 In Combination With Keytruda (Pembrolizumab) For Endometrial Cancer, In A Phase 1 Trial
Ideaya Biosciences已与默沙东签订了临床试验合作和供应协议，以评估其 IDEE161 与 Keytruda（Pembrolizumab）联合用于子宫内膜癌的 1 期试验